{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:27:13Z","timestamp":1793158033105,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003769","name":"Eisai Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.tjpad.2025.100215","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T15:47:59Z","timestamp":1749224879000},"page":"100215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The patient pathway for mild cognitive impairment due to Alzheimer\u2019s disease in Asia: Current practices, barriers, and expert recommendations for optimization"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4180-8626","authenticated-orcid":false,"given":"Seong Hye","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9101-5704","authenticated-orcid":false,"given":"SangYun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0787-2907","authenticated-orcid":false,"given":"Paulus Anam","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai Vyrn","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2017-7797","authenticated-orcid":false,"given":"Jacqueline","family":"Dominguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1047-9225","authenticated-orcid":false,"given":"Christopher Li-Hsian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vorapun","family":"Senanarong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaur-Jong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjari","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Mok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6608-2841","authenticated-orcid":false,"given":"Gandan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9351-4021","authenticated-orcid":false,"given":"Amitabh","family":"Dash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tjpad.2025.100215_bib0001","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.937486","article-title":"Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2019","volume":"14","author":"Li","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.tjpad.2025.100215_bib0002","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019","volume":"7","author":"Nichols","year":"2022","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.tjpad.2025.100215_bib0003","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s association workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100215_bib0004","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3233\/ADR-230029","article-title":"Plasma biomarkers of Alzheimer's disease: a review of available assays, recent developments, and implications for clinical practice","volume":"7","author":"Pais","year":"2023","journal-title":"J Alzheimers Dis Rep"},{"key":"10.1016\/j.tjpad.2025.100215_bib0005","doi-asserted-by":"crossref","first-page":"426","DOI":"10.14283\/jpad.2023.43","article-title":"Diagnostic biomarkers of amyloid and tau pathology in Alzheimer\u2019s disease: an overview of tests for clinical practice in the United States and Europe","volume":"10","author":"Iaccarino","year":"2023","journal-title":"J Prev Alzheimer's Dis"},{"key":"10.1016\/j.tjpad.2025.100215_bib0006","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40035-022-00296-z","article-title":"Advances in the development of new biomarkers for Alzheimer's disease","volume":"11","author":"Klyucherev","year":"2022","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.tjpad.2025.100215_bib0007","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/alz.12638","article-title":"2022 Alzheimer's disease facts and figures","volume":"18","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100215_bib0008","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100215_bib0009","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","article-title":"Amyloid \u03b2 deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study","volume":"12","author":"Villemagne","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.tjpad.2025.100215_bib0010","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S1474-4422(23)00128-X","article-title":"The complex pathway between amyloid \u03b2 and cognition: implications for therapy","volume":"22","author":"Jagust","year":"2023","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.tjpad.2025.100215_bib0011","doi-asserted-by":"crossref","first-page":"111cm33","DOI":"10.1126\/scitranslmed.3002609","article-title":"Testing the right target and right drug at the right stage","volume":"3","author":"Sperling","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.tjpad.2025.100215_bib0012","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.tjpad.2025.100215_bib0013","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease","volume":"388","author":"van Dyck","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tjpad.2025.100215_bib0014","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.40027","article-title":"National dementia plans of group of seven countries and South Korea based on international recommendations","volume":"5","author":"Seong","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.tjpad.2025.100215_bib0015","doi-asserted-by":"crossref","first-page":"152","DOI":"10.17340\/jkna.2018.3.3","article-title":"National responsibility policy for dementia care: current and future","volume":"36","author":"Choi","year":"2018","journal-title":"J Korean Neurol Assoc"},{"key":"10.1016\/j.tjpad.2025.100215_bib0016","article-title":"The impact of the implementation of a national policy on dementia on healthcare costs in older patients with dementia in Korea: a quasi-experimental difference-in-difference study","volume":"44","author":"Choi","year":"2024","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.tjpad.2025.100215_bib0017","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.healthpol.2020.11.003","article-title":"A decade of public long-term care insurance in South Korea: policy lessons for aging countries","volume":"125","author":"Kim","year":"2021","journal-title":"Health Policy"},{"key":"10.1016\/j.tjpad.2025.100215_bib0018","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4235\/agmr.20.0082","article-title":"Is Korea prepared for an Alzheimer's disease-modifying therapy? Assessing the Korean healthcare system infrastructure and the effect of blood-based biomarker tests","volume":"25","author":"Jun","year":"2021","journal-title":"Ann Geriatr Med Res"},{"key":"10.1016\/j.tjpad.2025.100215_bib0019","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.26633\/RPSP.2020.2","article-title":"National policy actions on dementia in the Americas and Asia-Pacific: consensus and challenges","volume":"44","author":"Sun","year":"2020","journal-title":"Rev Panam Salud Publica"},{"key":"10.1016\/j.tjpad.2025.100215_bib0020","first-page":"292","article-title":"Taiwan dementia treatment guideline","volume":"15","author":"Huang","year":"2021","journal-title":"Int J Gerontol"},{"key":"10.1016\/j.tjpad.2025.100215_bib0021","series-title":"Assessing the preparedness of the U.S. health care system infrastructure for an Alzheimer's treatment","author":"Liu","year":"2017"},{"key":"10.1016\/j.tjpad.2025.100215_bib0022","doi-asserted-by":"crossref","first-page":"2","DOI":"10.7249\/rhq-08-03-02","article-title":"Assessing the preparedness of the health care system infrastructure in six European countries for an Alzheimer's treatment","volume":"8","author":"Hlavka","year":"2019","journal-title":"Rand Health Q"},{"key":"10.1016\/j.tjpad.2025.100215_bib0023","unstructured":"Alzforum. Leqembi: side effects no worse in clinical use than they were in trial. 2024. https:\/\/www.alzforum.org\/news\/conference-coverage\/leqembi-side-effects-no-worse-clinical-use-they-were-trial. Accessed 6 May 2025."},{"key":"10.1016\/j.tjpad.2025.100215_bib0024","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s13195-024-01568-8","article-title":"Public perceptions related to healthcare preparedness to anti-amyloid therapies for Alzheimer's disease in Japan","volume":"16","author":"Sato","year":"2024","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.tjpad.2025.100215_bib0025","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.1002\/alz.13348","article-title":"Preparedness of China's health care system to provide access to a disease-modifying Alzheimer's treatment","volume":"19","author":"Mattke","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100215_bib0026","first-page":"3637954","article-title":"Physician perceptions about the barriers to prompt diagnosis of mild cognitive impairment and Alzheimer\u2019s disease","volume":"2019","author":"Judge","year":"2019","journal-title":"Int J Alzheimers Dis"},{"key":"10.1016\/j.tjpad.2025.100215_bib0027","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12889-024-17671-2","article-title":"Changes in dementia treatment patterns associated with changes in the National Policy in South Korea among patients with newly diagnosed Alzheimer\u2019s disease between 2011 and 2017: results from the multicenter, retrospective CAPTAIN study","volume":"24","author":"Kim","year":"2024","journal-title":"BMC Public Health"},{"key":"10.1016\/j.tjpad.2025.100215_bib0028","doi-asserted-by":"crossref","first-page":"562","DOI":"10.2214\/AJR.22.28461","article-title":"Amyloid-related imaging abnormalities: an update","volume":"220","author":"Roytman","year":"2023","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.tjpad.2025.100215_bib0029","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1017\/cjn.2023.322","article-title":"Health system change for Alzheimer\u2019s disease-modifying therapies in Canada: beginning the discussion","volume":"51","author":"Frank","year":"2024","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.tjpad.2025.100215_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-240684","article-title":"A framework for best practices and readiness in the advent of anti-amyloid therapy for early Alzheimer's disease in Asia","volume":"101","author":"Lee","year":"2024","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.tjpad.2025.100215_bib0031","article-title":"Dementia diagnostic and treatment services in the Western Pacific: challenges, preparedness and opportunities in the face of amyloid-targeting therapies","volume":"50","author":"O'Callaghan","year":"2024","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.tjpad.2025.100215_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.tjpad.2025.100068","article-title":"Use of lecanemab and donanemab in the Canadian healthcare system: evidence, challenges, and areas for future research","volume":"12","author":"Smith","year":"2025","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.tjpad.2025.100215_bib0033","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/s43587-022-00269-x","article-title":"Designing the next-generation clinical care pathway for Alzheimer's disease","volume":"2","author":"Hampel","year":"2022","journal-title":"Nat Aging"},{"key":"10.1016\/j.tjpad.2025.100215_bib0034","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.dadm.2015.03.003","article-title":"The Quick Dementia Rating System (QDRS): a rapid dementia staging tool","volume":"1","author":"Galvin","year":"2015","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.1016\/j.tjpad.2025.100215_bib0035","doi-asserted-by":"crossref","first-page":"362","DOI":"10.14283\/jpad.2023.30","article-title":"Lecanemab: appropriate use recommendations","volume":"10","author":"Cummings","year":"2023","journal-title":"J Prev Alzheimers Dis"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580725001591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580725001591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T12:18:54Z","timestamp":1786018734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580725001591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S2274580725001591"],"URL":"https:\/\/doi.org\/10.1016\/j.tjpad.2025.100215","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The patient pathway for mild cognitive impairment due to Alzheimer\u2019s disease in Asia: Current practices, barriers, and expert recommendations for optimization","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjpad.2025.100215","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS on behalf of SERDI Publisher.","name":"copyright","label":"Copyright"}],"article-number":"100215"}}